Toxicogenomics: Japanese initiative

Handbook of Toxicogenomics: A Strategic View of Current Research and Applications

Volumn , Issue , 2005, Pages 623-631

  Urushidani, Tetsuro ^a   Nagao, Taku ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TOXICOGENOMICS;

EID: 84956761866     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527603719.ch26     Document Type: Chapter

References (6)

1. Dennis, C., Gallagher, R. Campbell, P. Everyone's genome. Nature 2001, 409, 813.
2. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N.,Chou J.L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245, 1066-1073.
3. Laurence, R.N. Sir Richard Sykes contemplates the future of the pharma industry. Drug Discovery Today 2002, 7, 645-648.
4. Japan Pharmaceutical Manufacturers Association (2002). Success Rate of Developing New Drugs. http://www/jpma.or.jp/12english/index09.html.
5. Kennedy, T. Managing the drug discovery/development interface. Drug Discovery Today 1997, 2, 436-444.
6. Kanno, J. Reverse toxicology as a future predictive toxicology. In: Inoue T. and Pennie, W.D. (Eds.) Toxicogenomics. Springer-Verlag, Berlin, Heidelberg, New York, 2003, 213-218.